Oooo - fractions! Sorry, but you already lost lots of people at that point.
As for their ability to read this:
To date, 343 (85%) pts remain on therapy, 60 (15%) have discontinued (42 BP/ALL): 24 (6%) progressive disease (20 BP/ALL); 11 (3%) AE (3 pain, 3 thrombocytopenia, 1 each haemorrhage, loss of consciousness, enterocolitis, cytokine release syndrome, hepatotoxicity/pleuro-pericardial effusion after overdose); 8 (2%) died (3 related; 7 BP/ALL); 17 (4%) other.
and realize that of those patients who did not have blast-phase ALL, exactly one died while on treatment and exactly four had their disease progress, well, I guess we'll have to wait for tomorrow for it to sink in....
EDIT: Personally, I'd like to know the overlap here:
8 (2%) died (3 related; 7 BP/ALL)
but ultimately, I think it will be of little importance.
(Someone please correct me if I'm misreading this!)